Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer.
Acharyya RK, Rej RK, Hu B, Chen Z, Wu D, Lu J, Metwally H, McEachern D, Wang Y, Jiang W, Bai L, Tošović J, Gersch CL, Xu G, Zhang W, Wu W, Priestley ES, Sui Z, Sarkari F, Wen B, Sun D, Rae JM, Wang S.
Acharyya RK, et al. Among authors: zhang w.
J Med Chem. 2024 Nov 1. doi: 10.1021/acs.jmedchem.4c01521. Online ahead of print.
J Med Chem. 2024.
PMID: 39485242